Issue navigation
Volume 23, Issue 3, 1 March 2017
Letters to the Editor
Reply
Shirley Cohen-Mekelburg and others
Inflammatory Bowel Diseases, Volume 23, Issue 3, 1 March 2017, Page E14, https://doi.org/10.1097/MIB.0000000000001032
Elevated C-Reactive Protein in Asymptomatic Crohn's Disease Patients: Listen to the Sound of Silence
Cristiano Pagnini and others
Inflammatory Bowel Diseases, Volume 23, Issue 3, 1 March 2017, Page E13, https://doi.org/10.1097/MIB.0000000000001030
Reply
Abhik Bhattacharya
Inflammatory Bowel Diseases, Volume 23, Issue 3, 1 March 2017, Pages E13–E14, https://doi.org/10.1097/MIB.0000000000001037
IBD Live
Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases
Subrata Ghosh and others
Inflammatory Bowel Diseases, Volume 23, Issue 3, 1 March 2017, Pages 333–340, https://doi.org/10.1097/MIB.0000000000001033
Self-efficacy and Resilience Are Useful Predictors of Transition Readiness Scores in Adolescents with Inflammatory Bowel Diseases
Katrine Carlsen and others
Inflammatory Bowel Diseases, Volume 23, Issue 3, 1 March 2017, Pages 341–346, https://doi.org/10.1097/MIB.0000000000001038
Clinical Review Article
Predictors of Hospital Readmissions for Ulcerative Colitis in the United States: A National Database Study
Priti Poojary and others
Inflammatory Bowel Diseases, Volume 23, Issue 3, 1 March 2017, Pages 347–356, https://doi.org/10.1097/MIB.0000000000001041
Future Directions and Methods for IBD Research
Self-managed eHealth Disease Monitoring in Children and Adolescents with Inflammatory Bowel Disease: A Randomized Controlled Trial
Katrine Carlsen and others
Inflammatory Bowel Diseases, Volume 23, Issue 3, 1 March 2017, Pages 357–365, https://doi.org/10.1097/MIB.0000000000001026
Original Article
Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis
Yong Huang and others
Inflammatory Bowel Diseases, Volume 23, Issue 3, 1 March 2017, Pages 366–378, https://doi.org/10.1097/MIB.0000000000001027
The α4β1 Homing Pathway Is Essential for Ileal Homing of Crohn's Disease Effector T Cells In Vivo
Sebastian Zundler and others
Inflammatory Bowel Diseases, Volume 23, Issue 3, 1 March 2017, Pages 379–391, https://doi.org/10.1097/MIB.0000000000001029
Epithelial-specific Toll-like Receptor (TLR)5 Activation Mediates Barrier Dysfunction in Experimental Ileitis
Loris R. Lopetuso and others
Inflammatory Bowel Diseases, Volume 23, Issue 3, 1 March 2017, Pages 392–403, https://doi.org/10.1097/MIB.0000000000001035
Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease—the Israeli Real-World Experience
Uri Kopylov and others
Inflammatory Bowel Diseases, Volume 23, Issue 3, 1 March 2017, Pages 404–408, https://doi.org/10.1097/MIB.0000000000001039
Factors Associated with Discontinuation of Anti-TNF Inhibitors Among Persons with IBD: A Population-Based Analysis
Laura E. Targownik and others
Inflammatory Bowel Diseases, Volume 23, Issue 3, 1 March 2017, Pages 409–420, https://doi.org/10.1097/MIB.0000000000001025
Ultrasound Shear Wave Elastography and Contrast Enhancement: Effective Biomarkers in Crohn's Disease Strictures
Cathy Lu and others
Inflammatory Bowel Diseases, Volume 23, Issue 3, 1 March 2017, Pages 421–430, https://doi.org/10.1097/MIB.0000000000001020
Development and Validation of a Questionnaire to Assess the Quality of Life in Patients with Inflammatory Bowel Disease in Mainland China
Jiayin Ruan and others
Inflammatory Bowel Diseases, Volume 23, Issue 3, 1 March 2017, Pages 431–439, https://doi.org/10.1097/MIB.0000000000001024
Methotrexate for Refractory Crohn's Disease Compared with Thiopurines: A Retrospective Non-head-to-head Controlled Study
Zicheng Huang and others
Inflammatory Bowel Diseases, Volume 23, Issue 3, 1 March 2017, Pages 440–447, https://doi.org/10.1097/MIB.0000000000001022
Nodular Regenerative Hyperplasia of the Liver in Patients with IBD Treated with Allopurinol–Thiopurine Combination Therapy
Margien L. Seinen and others
Inflammatory Bowel Diseases, Volume 23, Issue 3, 1 March 2017, Pages 448–452, https://doi.org/10.1097/MIB.0000000000001036
Long-term Efficacy and Safety of Adalimumab in Pediatric Patients with Crohn's Disease
William A. Faubion and others
Inflammatory Bowel Diseases, Volume 23, Issue 3, 1 March 2017, Pages 453–460, https://doi.org/10.1097/MIB.0000000000001021
Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis
Stephanie Coward and others
Inflammatory Bowel Diseases, Volume 23, Issue 3, 1 March 2017, Pages 461–472, https://doi.org/10.1097/MIB.0000000000001023
Evidence of Bidirectional Associations Between Perceived Stress and Symptom Activity: A Prospective Longitudinal Investigation in Inflammatory Bowel Disease
Kathryn A. Sexton and others
Inflammatory Bowel Diseases, Volume 23, Issue 3, 1 March 2017, Pages 473–483, https://doi.org/10.1097/MIB.0000000000001040
Advertisement
Advertisement